Black Rock Inc. Inozyme Pharma, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,343,193 shares of INZY stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,343,193

Previous 3,088,653 8.24%

Holding current value

$13.4 Million

Previous $23.7 Million 36.98%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.33 - $7.31 $1.1 Million - $1.86 Million	254,540 Added 8.24%	3,343,193 $14.9 Million
Q1 2024 May 10, 2024	BUY	$4.14 - $7.66 $191,777 - $354,834	46,323 Added 1.52%	3,088,653 $23.7 Million
Q4 2023 Feb 13, 2024	BUY	$2.71 - $4.5 $2.18 Million - $3.61 Million	802,588 Added 35.83%	3,042,330 $13 Million
Q3 2023 Nov 13, 2023	BUY	$4.09 - $7.0 $1.23 Million - $2.1 Million	300,082 Added 15.47%	2,239,742 $9.41 Million
Q2 2023 Aug 11, 2023	BUY	$4.93 - $6.74 $7.34 Million - $10 Million	1,488,467 Added 329.9%	1,939,660 $10.8 Million
Q1 2023 May 12, 2023	BUY	$1.3 - $5.73 $32,459 - $143,072	24,969 Added 5.86%	451,193 $2.59 Million
Q4 2022 Feb 13, 2023	SELL	$1.05 - $2.82 $2,317 - $6,223	-2,207 Reduced 0.52%	426,224 $447,000
Q3 2022 Nov 14, 2022	SELL	$2.57 - $5.45 $5,368 - $11,385	-2,089 Reduced 0.49%	428,431 $1.15 Million
Q2 2022 Aug 12, 2022	SELL	$3.2 - $5.96 $1.43 Million - $2.67 Million	-447,880 Reduced 50.99%	430,520 $2.05 Million
Q1 2022 May 12, 2022	BUY	$3.87 - $7.55 $160,225 - $312,585	41,402 Added 4.95%	878,400 $3.59 Million
Q4 2021 Feb 10, 2022	SELL	$5.58 - $11.5 $355,563 - $732,791	-63,721 Reduced 7.07%	836,998 $5.71 Million
Q3 2021 Nov 09, 2021	BUY	$11.12 - $19.4 $9,407 - $16,412	846 Added 0.09%	900,719 $10.4 Million
Q2 2021 Aug 11, 2021	BUY	$15.19 - $21.2 $13.7 Million - $19.1 Million	899,873 New	899,873 $15.3 Million

Others Institutions Holding INZY

# of Institutions

Shares Held

51.9M

Call Options Held

162K

Put Options Held

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $161M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account